VEGF signaling may induce CXCL2 secretion by tumor-associated macrophages (TAMs) or other cell types, attracting more monocytes into the tumor microenvironment through immune cell recruitment at the tumor site. This evidence concerns the gene CXCL2 and neoplasm.